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ABSTRACT
Food allergies are classified into three types, “IgE-mediated,” “combined IgE- and cell-mediated” and “cell-
mediatednon-IgE-mediated,” depending on the involvement of IgE in their pathogenesis. Patients who de-
velop predominantly cutaneous andor respiratory symptoms belong to the IgE-mediated food allergy type. On
the other hand, patients with gastrointestinal food allergy (GI allergy) usually develop gastrointestinal symp-
toms several hours after ingestion of offending foods; they belong to the cell-mediatednon-IgE-mediated or
combined IgE- and cell-mediated food allergy types. GI allergies are also classified into a number of different
clinical entities: food protein-induced enterocolitis syndrome (FPIES), food protein-induced proctocolitis (FPIP),
food protein-induced enteropathy (Enteropathy) and eosinophilic gastrointestinal disorders (EGID). In the case
of IgE-mediated food allergy, the diagnostic approaches and pathogenic mechanisms are well characterized. In
contrast, the diagnostic approaches and pathogenic mechanisms of GI allergy remain mostly unclear.
In this review, we summarized each type of GI allergy in regard to its historical background and updated clini-
cal features, offending foods, etiology, diagnosis, examinations, treatment and pathogenesis. There are still
many problems, especially in regard to the diagnostic approaches for GI allergy, that are closely associated
with the definition of each disease. In addition, there are a number of unresolved issues regarding the patho-
genic mechanisms of GI allergy that need further study and elucidation. Therefore, we discussed some of the
diagnostic and research issues for GI allergy that need further investigation.
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INTRODUCTION
Food allergies continue to increase, especially in
westernized countries,1 and are now recognized as a
worldwide problem. Food allergies are classified into
three types: “IgE-mediated,” “combined IgE- and cell-
mediated” and “cell-mediatednon-IgE-mediated,” de-
pending on the involvement of IgE in their patho-
genesis.1-3
Most food allergies that exhibit cutaneous andor
respiratory symptoms within 1 hour after ingestion of
offending foods belong to IgE-mediated food aller-
gies. The mechanisms and pathogenesis of IgE-
mediated food allergies are well characterized. In
brief, food-specific IgE antibodies are generated after
initial exposure to food antigens and then bind to the
surface of mast cells and basophils. Upon re-exposure
to the offending foods, the food antigens bind to and
cross-link the food-specific IgE antibodies bound to
the mast cells and basophils, causing their activation
and degranulation. Released mediators such as hista-
mine and leukotrienes cause cutaneous andor respi-
ratory symptoms (Fig. 1).4 These mechanisms were
supported by the existence of serum IgE antibodies
specific for offending foods and elevation of the se-
rum histamine level after ingestion of offending
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Fig.　1　Pathogenic mechanisms of IgE-mediated food allergy and gastrointestinal food allergy. (a) IgE-medi-
ated food allergy. Th2 cytokines such as IL-4 and IL-13, which are produced by T cells in response to specifi c 
food antigens, induce B cells to produce food-specifi c IgE antibodies. The food-specifi c IgE antibodies bind to 
the surface of mast cells. Upon re-exposure to the offending food, the food-specifi c IgE antibodies become 
cross-linked on the surface of the mast cells, triggering activation and degranulation of the cells. Released 
mediators, such as histamine and leukotrienes, cause cutaneous and/or respiratory symptoms. (b) Gastroin-
testinal food allergy. Unlike IgE-mediated food allergy, large amounts of infl ammatory cytokines such as TNF-
α are also produced antigen-specifi cally by T cells in GI allergies. TNF-α increases intestinal permeability, 
which facilitates the uptake of undigested food antigens. On the other hand, as in the case of IgE-mediated 
food allergy, Th2 cytokines such as IL-4, IL-5 and IL-13 are produced by T cells in response to specifi c food 
antigens. However, B cells do not produce food antigen-specifi c IgE antibodies in most patients with GI aller-
gy. IL-13 induces intestinal epithelial damage through activation of the tumor necrosis factor-like weak induc-
er of apoptosis-fi broblast growth factor-inducible molecule 14 (TWEAK-Fn14) axis. IL-5 accumulates and ac-
tivates eosinophils in gastrointestinal tissues.
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foods.5 Positive skin-prick tests and significant hista-
mine release from peripheral blood basophils after
stimulation with offending food proteins in vitro also
support these concepts. In some patients, gastrointes-
tinal symptoms such as vomiting and diarrhea are ac-
companied by cutaneous andor respiratory symp-
toms. However, the gastrointestinal symptoms usu-
ally appear within 1 hour after ingestion of offending
foods,1 and they are also surmised to be induced by
IgE-mediated immune responses.
Unlike IgE-mediated food allergy, some patients
exhibit gastrointestinal symptoms such as vomiting,
diarrhea and bloody stool several hours (at least 1
hour) after ingestion of offending foods, with only
rare cutaneous or respiratory manifestations. Those
patients are diagnosed as having a subtype of food al-
lergy, called gastrointestinal food allergy (GI al-
lergy).6 Specific IgE antibodies to offending foods are
rarely detected in sera from patients with GI allergy,
especially infants. Therefore, GI allergy is thought to
be “cell-mediatednon-IgE-mediated” or “combined
IgE- and cell-mediated” disease. However, the precise
mechanisms and pathogenesis of GI allergy remain
unclear.
GI allergy has classically encompassed a number
of different clinical entities: food protein-induced en-
terocolitis syndrome (FPIES), food protein-induced
proctocolitis (FPIP), food protein-induced enteropa-
thy and eosinophilic gastrointestinal disorders
(EGID).2 In the first three, most patients are infants
and rarely have detectable food-specific IgE antibod-
ies. Therefore, they have been classified as non-IgE-
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mediated diseases. On the other hand, most patients
with EGID are adults and young children, and often
have detectable food-specific IgE antibodies. There-
fore, EGID has been classified as combined IgE- and
cell-mediated disease. However, these classifications
evolved from different perspectives: the clinical mani-
festation for the first three entities, and the histologi-
cal findings for the last. Therefore, there must be
some overlap between these clinical entities.7
In this review, we trace the history of GI allergy in
the literature and summarize the defining features of
each disease. We have also tried to elucidate unre-
solved issues regarding each disease that require fur-
ther investigation.
FOOD PROTEIN-INDUCED ENTEROCOLI-
TIS SYNDROME ( FPIES ) ( DIETARY
PROTEIN-INDUCED ENTEROCOLITIS SYN-
DROME)
HISTORY
In 1967, Gryboski reported a series of 21 children
who developed vomiting andor diarrhea after inges-
tion of milk.8 In 1986, Powell characterized the clini-
cal features of such patients, established diagnostic
criteria and coined the term “food protein-induced en-
terocolitis of infancy”.9 Subsequently, Sicherer et al.
established the term “Food Protein-Induced Entero-
colitis Syndrome (FPIES)”.10
CLINICAL FEATURES
Patients with FPIES experience repetitive vomiting,
starting one or two hours after ingestion of offending
foods, followed by diarrhea.9-16 However, these pa-
tients do not develop acute cutaneous or respiratory
symptoms, which commonly accompany IgE-
mediated food allergy.9-13,15 Although most patients
develop symptoms at least one hour after ingestion of
offending foods, total nine patients who have devel-
oped symptoms within one hour after ingestion of of-
fending foods were reported.10,17
FPIES is sometimes accompanied by systemic
symptoms such as hypotension,9-12,14,17,18 leth-
argy, 9,11-13,17 pallor, 13 hypothermia, 13 bloody
stool,12,17-19 ileus,19,20 methemoglobinemia10,13,14,21
and thrombocytosis.13,22 Some FPIES patients also
develop a high fever, with neutrophilia. Therefore,
these patients are sometimes initially mistakenly di-
agnosed as sepsis or surgical abdominal emergency,
etc.13,22-24
Although comparatively acute onset after ingestion
of offending foods is a characteristic feature of FPIES
compared with other GI allergy entities, as stated
above, some patients with FPIES exhibit a chronic
clinical course.13,25 The reason for this remains un-
clear.
OFFENDING FOODS
The most common causal foods of FPIES are cow’s
milk and soy-based formulas. However, solid foods
such as rice,13,16,17,26-29 oats,13,17 eggs,16,30,31 barley,17
sweet potato,13,17 chicken,10,13,17,29,32,33 turkey,10,17,32
peas,10,17,32 bananas,13 fish,13,16,17,29 lamb,13 corn,16,34
and orange juice35 have also been reported as causal
foods. Breast feeding was previously thought to be a
protective factor, but recent reports documented five
patients with FPIES who reacted to cow’s milk or soy
protein passed through the breast milk.25,36,37
ETIOLOGY
A prospective population-based study in Israel re-
ported that the incidence of milk-induced FPIES was
0.34%.38 Age at onset of typical FPIES caused by
cow’s milk or soy-based formula was reported to be
less than 9 months of age. However, some patients
develop FPIES later than 9 months.10-12 In addition,
the mean age at onset of FPIES caused by solid foods
tends to be higher than that of FPIES caused by
cow’s milk or soy-based formula. A recent report indi-
cates that even adults may develop FPIES caused by
solid foods.39
DIAGNOSIS
Powell initially defined FPIES based on four criteria.9
(1) Disappearance of the symptoms of vomiting and
diarrhea, and of blood and leukocytes in the stool, af-
ter all antigens are removed from the diet. (2) No
other cause for the colitis is demonstrable. (3) Symp-
toms do not recur and weight gain is normal for one
month on a low-antigen formula. (4) Challenge with
milk or soy formula, or other offending food antigens,
reproduces symptoms. Powell also proposed a de-
tailed method for oral food challenge (OFC) as a di-
agnostic test and criteria for positive responses.
Briefly, when more than three of the following five
criteria are positive, the challenge is considered posi-
tive9: (1) vomiting andor diarrhea symptoms, (2)
blood in the stool, (3) leukocytes in the stool, (4)
eosinophils in the stool and (5) a change in the blood
polymorphonuclear neutrophil count. Although OFC
is the most conclusive diagnostic method, it has been
associated with a risk of systemic reac-
tions.9-12,14,17,18,21 Therefore, OFC for diagnostic con-
firmation can be omitted when the clinical course is
typical.15 In recent years, the diagnostic criteria de-
scribed by Sicherer have been more commonly
used.10 They are: (1) younger than 9 months of age at
initial diagnosis, (2) repeated exposure to the incrimi-
nated food elicited diarrhea andor repetitive vomit-
ing within 24 hours without any other plausible cause
for the symptoms, (3) there were no symptoms other
than gastrointestinal symptoms elicited by the in-
criminated food and (4) removal of the offending pro-
tein from the diet resulted in resolution of the symp-
toms, andor a standardized food challenge elicited
diarrhea andor vomiting within 24 hours after ad-
ministration of the food.
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EXAMINATIONS
The skin-prick test (SPT)13,17 and specific IgE anti-
bodies13 for offending foods in the serum are nega-
tive in the majority of patients with FPIES at the time
of diagnosis. However, some patients have detectable
IgE10,17,36,38 and positive SPT reactions16,38,40 to of-
fending foods. The symptoms in these patients tend
to persist,10,15 and those patients often develop IgE-
mediated food allergy.16,38,40,41 However, the role of
such specific IgE antibodies in the pathogenesis of
FPIES remains unclear.
The antigen-specific lymphocyte stimulation test
(ALST) is a well-known method for investigating
antigen-specific T-cell responses and theoretically
should be suitable for diagnosis of FPIES that is
thought to be cell-mediated. However, the usefulness
of ALST for diagnosis of FPIES has been controver-
sial.42-45 We recently found that certain amounts of
lipopolysaccharide (LPS) that contaminated commer-
cially available cow’s milk proteins used in previous
reports are able to induce proliferative responses that
are antigen-non-specific. In addition, the lymphopro-
liferative response to LPS was higher in neonates
than in young children.46 Therefore, ALST could be a
helpful tool for diagnosis of FPIES if LPS-depleted
cow’s milk protein preparations are used.
Fogg reported the usefulness of the atopy patch
test (APT) for initial diagnosis of FPIES, with 100%
sensitivity, 71% specificity, 75% positive predictive
value and 100% negative predictive value.47 However,
a more recent report found that APT does not predict
outgrowing of FPIES (11.8% sensitivity, 85.7% speci-
ficity, 40% positive predictive value and 54.5% negative
predictive value).48 Further studies are needed to elu-
cidate the usefulness of APT for initial diagnosis and
prediction of outgrowing FPIES.
TREATMENT
The primary therapy for FPIES is to avoid the causal
food antigens, just as for IgE-mediated food allergies.
In infantile cases of FPIES caused by cow’s milk,
breastfeeding tends to be protective. Therefore, 1)
exclusive breastfeeding is recommended when possi-
ble. However, a small number patients with FPIES re-
act to cow’s milk or soy protein passed through the
breast milk.25,36,37 Thus, some account should be
taken of this possibility. 2) If exclusive breastfeeding
is impossible, cow’s milk should be replaced with
other nutrition, such as a hydrolysate-based formula,
soy-based formula or amino acid formula. Among
those formulas, hydrolysate-based formula is prefer-
able to soy-based formula, because it was reported
that about half of FPIES patients are sensitive to both
milk and soy.10,17,47,49,50 However, recent reports indi-
cate that the rates of coexisting milk and soy sensitiv-
ity are much lower than formerly thought.13,38 3) On
the other hand, some patients tend to react even to
hydrolysate-based formula.51-53 For them, an amino
acid formula is needed.
PATHOGENESIS
The histological findings of patients with FPIES have
been reported to be uncharacteristic inflammation:
edema, villous atrophy and cellular infiltration in the
duodenum and jejunum.54,55 However, TNF-α expres-
sion in the epithelial cells and mononuclear cells in
the lamina propria was markedly increased in FPIES
patients, especially those having villous atrophy.55 In
addition, TNF-α was highly secreted, antigen-
specifically, by PBMC from patients with FPIES46,56,57
and was also increased in the stool after milk chal-
lenge of patients with gastrointestinal milk al-
lergy.58,59 TNF-α is known to increase intestinal per-
meability.57,60 Therefore, TNF-α could be involved in
the pathogenesis of FPIES through alteration of intes-
tinal permeability.
Thrombocytosis and leukocytosis after ingestion of
offending foods are sometimes observed in patients
with FPIES.13,22 In addition, C-reactive protein (CRP)
is often elevated in the sera from patients with GI al-
lergy.36,61,62 Both reactive thrombocytosis and eleva-
tion of CRP are known to be induced by IL-6. We re-
cently found that IL-6 was highly produced, antigen-
specifically, by PBMC from patients with GI allergy.46
Thus, in addition to TNF-α, IL-6 may play some role
in the pathogenesis of FPIES.
FOOD PROTEIN-INDUCED PROCTOCOLI-
TIS (FPIP) (DIETARY PROTEIN-INDUCED
COLITIS)
HISTORY
Cases of infants with rectal bleeding in the first few
months of life have been reported since the
1950s.63-67 However, in most cases no direct cause for
rectal bleeding was able to be identified. In 1982,
Lake et al. first suggested cow’s milk protein passed
through breast milk as a possible cause of rectal
bleeding, which they experienced in a series of 6 in-
fants who developed bloody diarrhea in the first
month of life while being exclusively breast fed.68 All
6 patients improved after being switched to hydro-
lyzed milk or soy-based formula, and the bloody diar-
rhea relapsed in all after being switched back to
breast milk. In addition, elimination of cow’s milk pro-
tein from the maternal diet led to tolerance of breast
milk in 2 of 5 patients. Therefore, Lake et al. named
those cases “dietary protein-induced colitis,” meaning
“food antigen-specific”.68 Sampson subsequently
termed it “food protein-induced proctocolitis”
(FPIP).69
CLINICAL FEATURES
Patients with FPIP typically develop grossly blood-
streaked stool with mucus in the first few months of
life. In contrast to FPIES, almost all patients with
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FPIP develop no systemic symptoms and seem to be
well except for the bloody stool. They have no growth
delay or poor weight gain.68,70-72 Mild anemia is seen
in rare cases.70,72-74 Many patients with FPIP are
breast-fed, and the cause is thought to be mainly
cow’s milk protein passed through the breast
milk.68,71,73,75 Cow’s milk and soy-based formulas are
the major causative foods in the remaining cases.74,76
Recently, FPIP have also been seen to manifest in
childhood.77 However, it remains unclear whether
FPIP in childhood has the same pathogenesis as that
in infants.
DIAGNOSIS
In 1982, Lake et al. observed a series of six infants
who developed bloody diarrhea caused by cow’s milk
protein passed through breast milk and confirmed
the antigen-specificity using both the antigen elimina-
tion test and OFC.68 Subsequently, there were many
reports of infants who developed bloody stool in the
first few months of life and showed resolution of the
symptoms after being switched to a hydrolyzed milk
or soy-based formula.73,74,76,78 Based on those re-
ports, subsequent papers have assigned a clinical di-
agnosis of FPIP without OFC to apparently healthy
infants with bloody stool and whose symptoms disap-
pear on an elimination diet.
However, recent studies have questioned the accu-
racy of the elimination diet in diagnosis of the
antigen-specificity of FPIP.79-81 To elucidate the effect
of a cow’s milk elimination diet on the duration and
severity of rectal bleeding in infants, Arvola et al.79
randomly assigned infants with bloody stool to start a
cow’s milk elimination diet or to continue their cur-
rent diet. As a result, the cow’s milk elimination diet
did not affect the duration or severity of rectal bleed-
ing between the two groups. In addition, only 2 of 19
patients who started the cow’s milk elimination diet
experienced recurrence of gastrointestinal symptoms
after reintroduction of cow’s milk protein.79 Jang et al.
reported that 10 of 16 patients with a chief complaint
of rectal bleeding showed resolution of symptoms
without any dietary change, while the remaining 6
cases responded to a cow’s milk elimination diet.
However, only 2 of those 6 responders developed
symptoms after OFC.81
These findings indicate that infants with bloody
stool might include a small percentage of patients
with FPIP that is actually caused in an antigen-
specific manner. In support of this notion, Ohtsuka et
al. reported 2 infants who had bloody stool on the
first day of life, before initial feeding, but subse-
quently never developed bloody stool even with
breast milk without maternal diet modification.82
These facts suggest that there are some special en-
teral environments in early infancy that may result in
antigen-nonspecific hemorrhage in the colon.
In that sense, patients with bloody stool whose anti-
gen specificity was confirmed by both an elimination
diet and OFC should be referred to as “true” FPIP.
However, in this review we are going to treat patients
with bloody stool as having FPIP even if they were di-
agnosed only by an elimination diet, without OFC.
Thus, a certain proportion of FPIP patients may have
antigen-nonspecific bloody stool, but in order to dis-
cuss FPIP, we must include these patients because
only little studies other than Lake et al.’s confirmed
antigen specificity in their subjects by OFC.
EXAMINATIONS
The endoscopic findings for FPIP are lymphonodular
hyperplasia (LNH), with an oozing and edematous
mucosal surface. The common histological features
are LNH70,71,78,83-86 and numerous eosinophils in the
lamina propria.70,71,73,74,76,78,83,86,87 Accordingly, appar-
ently healthy infants with bloody stool and LNH and
or numerous eosinophils in the lamina propria were
histologically diagnosed as FPIP and also called “al-
lergic colitis”.73,74,76,78,83
LNH in the colon has been reported to be associ-
ated with food allergy.88-90 LNH can also be observed
in other diseases, not just in FPIP.88,89,91 In addition,
Xanthakos reported several patients with LNH who
had spontaneous resolution of rectal bleeding without
any dietary change.80 These findings suggest that
LNH may be a self-limiting, age-related change, re-
gardless of the antigen specificity.
A histological finding of eosinophil infiltration (6
cellshigh power field (HPF)) in the lamina propria
was thought to be a useful threshold for diagnosis of
FPIP.75,83 However, DeBrosse et al. recently de-
scribed that eosinophils (mean 16-20 cellsHPF)
were normally observed in the gastrointestinal tract
of control children, especially in the colon.92 In addi-
tion, Jang et al. reported that only 2 of 10 patients
who exhibited marked eosinophil infiltration of the
lamina propria (more than 6 cellsHPF) developed
symptoms after OFC.81
Therefore, diagnosis of FPIP based on elimination
tests, the endoscopic findings and the histological
findings presents a risk of over-diagnosis. In this con-
text, for accurate diagnosis of FPIP, OFC after an
elimination diet should be recommended for appar-
ently healthy patients with bloody stool.
TREATMENT
As in the case of other food allergies, elimination of
causal food antigens is the gold-standard treatment
for FPIP. Many patients with FPIP are breast-fed in-
fants. Therefore, elimination of cow’s milk from the
maternal diet would be the first choice and an effec-
tive method.71 However, some patients still react to
breast milk even after the mother has strictly elimi-
nated cow’s milk from her diet.68,78,93 For such pa-
tients, the infant’s nutrition should be changed to a
hydrolyzed milk or soy-based formula. However,
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some patients respond even to hydrolyzed milk.51,78,80
For them, an amino acid formula is needed.
PATHOGENESIS
Based on the endoscopic and pathological findings,
activation of eosinophils and lymphocytes associated
with LNH is thought to play an important role in the
pathogenesis of FPIP. In support of this notion, Oht-
suka et al. recently showed that CCL11 (eotaxin-1)
mRNA and CXCL13 mRNA were highly expressed in
the large-intestine mucosa of infants with FPIP com-
pared with control subjects.94 However, the patho-
genic mechanisms underlying induction of eosino-
philic inflammation in the colon remain unclear.
INTESTINAL MICROBIOTA
Several investigator groups have reported an interest-
ing finding that delayed maturation of the intestinal
flora possibly causes rectal bleeding in infants.79,95,96
In normal newborn babies, there is transient intesti-
nal colonization by facultative anaerobes immediately
after birth. Thereafter, obligate anaerobes such as Bi-
fidobacterium, Bacteroides, Clostridium and Lactoba-
cillus species increase and establish colonization,
with reduction of facultative anaerobe counts. How-
ever, the counts of obligate anaerobes, especially Bifi-
dobacterium,79,95 Lactobacillus,79 Clostridium leptum
group (C. leptum) and Clostridium coccoides group
(C. coccoides),96 were significantly lower in the feces
of patients with FPIP than in healthy breast-fed in-
fants. These findings suggest that there is delayed
maturation of the intestinal flora in patients with
FPIP.
In addition, Atarashi et al. revealed that a mixture
of 46 strains of Clostridium spp., including C. leptum
and C. coccoides, promote regulatory T cell (Treg
cells) accumulation and also affect their function in
the colon of mice.97 The fact that there are lower
counts of C. leptum and C. coccoides in the feces of pa-
tients with FPIP suggests that impaired induction of
Treg cells in the colon may be involved in the patho-
genesis of FPIP. In support of this, Cseh et al. found
that the ratio of Treg cells in PBMC was lower in pa-
tients with FPIP than in control subjects.98 Moreover,
C. leptum and C. coccoides also promote accumulation
of IgA-positive cells in the colon99 and induce IgA pro-
duction through induction of Treg cells that produce
TGF-β.100 In support of this, secretory IgA concentra-
tions in the feces tend to be lower in patients with
FPIP than in control subjects.96 These findings sug-
gest that impaired induction of Treg cells and IgA
(which contribute to homeostasis in the intestine)
due to delayed maturation of the intestinal flora may
be a cause of FPIP. In fact, children who outgrew
their GI allergy had higher frequencies of circulating
Treg cells after OFC compared with children with
persistent GI allergy.101
However, it remains totally unknown how antigen-
specific immune responses link to delayed matura-
tion of the intestinal microbiota. Further investigation
is needed to elucidate whether the underlying mecha-
nisms are the same between patients with FPIP who
really respond to food antigens specifically and those
who do not.
FOOD PROTEIN-INDUCED ENTEROPATHY
(ENTEROPATHY)
HISTORY
Patients with food protein-induced enteropathy (En-
teropathy) were initially described by several investi-
gators in the 1960s as malabsorption syndromes
caused by cow’s milk protein.102-105 Subsequently, in
the late 1970s, such patients were described as hav-
ing “enteropathy induced by cow’s milk”.106,107
CLINICAL FEATURES
Patients with Enteropathy typically develop chronic
diarrhea and show poor weight gain in the first sev-
eral months of life.108 Mild to moderate anemia and
hypoproteinemia were seen in some patients with En-
teropathy.108 The clinical features of Enteropathy are
similar to those of celiac disease that is associated
with sensitivity to wheat protein. However, celiac dis-
ease is not included in this entity.
DIAGNOSIS
The diagnostic procedure for Enteropathy relies
heavily on elimination tests and OFC. Jejunal biopsy
is often helpful for diagnosis and follow-up.108
PATHOPHYSIOLOGY
The histological findings of patients with Enteropathy
were well characterized in the 1970s to 1980s. In
brief, jejunal biopsy specimens from patients with En-
teropathy showed various degrees of villous atrophy
with crypt hyperplasia,109-111 increased numbers of in-
traepithelial lymphocytes,108,112 and increased num-
bers of lymphocytes, plasma cells and eosinophils in
the lamina propria.113
Chung et al. reported that extracellular deposition
of major basic protein (MBP), which is an eosinophil
granule protein, in the lamina propria was signifi-
cantly higher in patients with Enteropathy than in
control subjects. In addition, extracellular deposition
of MBP correlated significantly with the severity of
mucosal villous atrophy.114 These findings suggest
that MBP released by eosinophils plays an important
role in the pathogenesis of Enteropathy by inducing
mucosal damage that leads to the villous atrophy.
However, patients with Enteropathy have rarely
been reported since 2000.115
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Fig.　2　Clinical and histological characterization of GI allergies. From the standpoint of an aller-
gist, GI allergies (FPIES, FPIP and Enterocolitis) are diseases characterized by antigen-specifi c 
immune responses (left-hand side). On the other hand, from the standpoint of a gastroenterolo-
gist, gastrointestinal diseases with eosinophil infi ltration are called eosinophilic esophagitis, gas-
troenteritis and colitis (right-hand side). The disease pathogenesis, especially how much these 
entities may overlap, warrants further investigation.
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CURRENT TOPICS AND FUTURE PER-
SPECTIVES
FOUR DISTINCT CLINICAL SUBTYPES IN NON-
IgE-MEDIATED FOOD ALLERGIES IN INFANTS
We recently tried to classify infants with gastrointesti-
nal symptoms by using cluster analysis of their clini-
cal and laboratory findings.36 We found that these pa-
tients can be classified into 4 distinct subtypes ac-
cording to the presence or absence of vomiting and
bloody stool. In brief, patients who had vomiting with
or without bloody stool were likely to be diagnosed as
having FPIES. Patients who had only bloody stool
were likely to be diagnosed as having proctocolitis.
Patients who had neither vomiting nor bloody stool
were likely to be diagnosed as having enteropathy. In
all four clusters, oral food challenge tests showed re-
markably high reproducibility of the symptoms found
at the initial presentation, even though the oral chal-
lenge tests were performed several months after the
initial presentation. This observation suggests that
the upper or lower gastrointestinal tract-specific hy-
persensitivity and perhaps the responsible immune
cells remain in the same part of the gastrointestinal
tract even after several months’ remission.
ROLE OF IgE ANTIBODIES IN GI ALLERGY
Some patients with non-IgE-mediated GI allergies
have detectable levels of food-specific IgE antibod-
ies.10,17,38 In the abovementioned study,36 a positive
milk-specific IgE antibody titer was observed in 37%
of the patients, with no statistically significant differ-
ences among any of the 4 subtypes. Interestingly, al-
most all symptoms at initial presentation as well as in
OFC began to manifest at more than two hours after
ingestion of the offending food, but no patients devel-
oped typical IgE-mediated symptoms such as urti-
caria or wheeze. These results strongly suggest that
the presence of milk-specific IgE antibody neither
fully explains the gastrointestinal symptoms nor rules
out a diagnosis of non-IgE-mediated GI allergy in in-
fants.
In contrast, EGID was classified as a combined
IgE- and cell-mediated disease because many patients
with EGID have detectable food-specific IgE antibod-
ies.7 However, the roles of IgE antibodies in the
pathogenesis of EGID remain unclear.
The precise roles of IgE antibodies in GI allergy
and EGID warrant further investigation.
CYTOKINE SECRETION PROFILES IN GI AL-
LERGY
We recently determined―for the first time―the
Morita H et al.
304 Allergology International Vol 62, No3, 2013 www.jsaweb.jp
antigen-specific cytokine secretion profiles of PBMC
from infants with non-IgE-mediated GI allergy using
extensively LPS-depleted milk antigens and 89 blood
samples originating from all over Japan through the
Japanese Research Group for Neonatal, Infantile Al-
lergic Disorders.46 We found significantly high con-
centrations of TH2 cytokines, but not TH1 or TH17
cytokines, in the culture supernatants of those
PBMC. The pathogenesis of non-IgE-mediated gas-
trointestinal allergy had been thought to be “non-TH
2” cell-mediated because IgE antibody is usually un-
detectable. However, our results strongly indicate
that the pathogenesis is, in fact, “TH2” cell-mediated.
In particular, high levels of IL-13 and TNF-α may play
critical roles in intestinal epithelial cell damage and
eosinophil infiltration, presumably through activation
of the tumor necrosis factor-like weak inducer of
apoptosis-fibroblast growth factor-inducible molecule
14 (TWEAK-Fn14) axis.116 However, it remains un-
clear why these patients do not produce antigen-
specific IgE antibodies. It may be due to reduced ex-
pression of the IL-4 receptor alpha chain and reduced
IL-4-induced signaling in neonatal B cells. Further
studies are needed to elucidate this issue.117
DISEASE ENTITIES OF GI ALLERGY AND EGID
The definitions and diagnostic criteria for GI allergy
and EGID were drawn up from different perspectives.
Non-IgE mediated diseases such as FPIES, FPIP and
Enteropathy are diagnosed mainly on the basis of the
clinical manifestation, as described earlier. On the
other hand, combined IgE- and cell-mediated dis-
eases such as EGID including eosinophilic gastroen-
teritis, eosinophilic colitis and eosinophilic esophagi-
tis (EoE) are diagnosed mainly on the basis of a sin-
gle histological finding, that is, inappropriate accumu-
lation of eosinophils in the gastrointestinal tract.118
However, many investigators reported that such ac-
cumulation is often observed even in patients with
non-IgE-mediated GI allergy. Therefore, there must
be some overlap and similar pathogenic mechanisms
between non-IgE-mediated GI allergy and EGID.7 In
support of this, we recently found that―along with
such inflammatory cytokines as TNF-α and IL-6―
Th2 cytokines, including IL-3, IL-5 and IL-13, but not
Th1 cytokine or Th17 cytokine, were significantly
produced in vitro by milk protein-stimulated PBMCs
from infant patients with GI allergy compared with
control subjects.46 These findings suggest that
antigen-specific Th2-type immune responses underlie
the pathogenesis of non-IgE-mediated GI-allergy
(Fig. 1).
The incidence of each GI allergy is relatively low in
comparison to that of IgE-mediated food allergy.38,62
Therefore, the diagnostic and classification criteria
depend heavily on small numbers of cases experi-
enced by various investigators and were drawn up
from their different standpoints, for example, as a pe-
diatrician, an allergist, a neonatologist and a gastroen-
terologist. The low prevalence and the different
standpoints may have strongly impacted on the differ-
ent diagnostic criteria for GI allergy and EGID (Fig.
2). To resolve this matter and to obtain a complete
view of GI allergy, we need to conduct a multicenter
study with cooperation among pediatricians, aller-
gists, neonatologists and gastroenterologists.
Fortunately, we have constructed a nation-wide da-
tabase using an internet online system and have ob-
tained data for over 500 patients with GI allergy,
thanks to the cooperation of doctors all over Japan.
That database has started to generate valuable re-
sults, step by step.36,46 We hope to carry out further
investigations that will fully elucidate the pathogene-
sis of GI allergy.
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